BIRC’s state-of-the-art technology unlocks Lenovo-Baidu smartphones with user’s voice.

The Agency for Science, Technology and Research’s (A*STAR) Genome Institute of Singapore (GIS) today announced the launch of a research collaboration with Appistry, a leading US-based provider of high-performance computing and analytics for managing and storing “big data.”

Innovation Clusters, or Hotspots, to include Diagnostics, Anti-Microbials, Bio-imaging, Printed Electronics and Business Analytics.

A*STAR’s Institute of Microelectronics (IME) and SFC Fluidics®, a USA microfluidics-based biomedical device development company, will be collaborating to develop a portable diagnostic tool for rapid triaging of traumatic brain injury (TBI) victims and to improve the treatment strategies.  TBI is one of the most common causes of death and disability in the world, usually resulting from blasts, falls, knocks, traffic accidents, and assaults.

This discovery holds the potential to reduce healthcare costs for many common inflammatory diseases such as cancer and diabetes.

Dr Bruno Reversade first scientist outside of Europe to win prestigious European award.

Based on a unique technology developed by A*STAR Singapore, these inventive and easy-to-use kits are versatile, effective and quick in the screening for modulators of protein-DNA interactions, as well as quality control (QC) analysis of transcription factor production.

Stratified medicine programme: deliver the right therapy to the right patient at the right time

Eye research: new clinical therapies to cure major eye diseases like glaucoma, corneal disease.

A*STAR’s GIS collaborates with pharmaceutical giant GlaxoSmithKline to further research on lung cancer